PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 44 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $7,000 | -30.0% | 17,075 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $10,000 | +11.1% | 17,075 | 0.0% | 0.00% | – |
| Q2 2015 | $9,000 | -35.7% | 17,075 | 0.0% | 0.00% | -100.0% |
| Q1 2015 | $14,000 | +27.3% | 17,075 | +21.3% | 0.00% | 0.0% |
| Q4 2014 | $11,000 | -50.0% | 14,075 | -34.8% | 0.00% | -50.0% |
| Q3 2014 | $22,000 | +15.8% | 21,575 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $19,000 | – | 21,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,226,961 | $221,000 | 0.02% |
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $10,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 1,077,555 | $107,000 | 0.00% |
| Cutter & CO Brokerage, Inc. | 79,500 | $8,000 | 0.00% |
| Virtu KCG Holdings LLC | 364,520 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 81,647 | $8,000 | 0.00% |
| WADE G W & INC | 80,000 | $8,000 | 0.00% |
| PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 29,358 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,500 | $0 | 0.00% |